Wednesday, May 6, 2020 | 11:00 – 12:15 pm
- Michael C. Rice, MS, MBA, Principal, Cello Health BioConsulting, previously Defined Health
- Robert Ang, MD, MBA, President & CEO, Vor BioPharma Inc.
- Jim Beitel, MD, PhD, SVP, Corporate Development, Fate Therapeutics Inc
- Julia Chapman, Director, Alliance Management, Precision BioSciences
- Thomas J. Farrell, President & CEO, Artiva Biotherapeutics
- Maksim Mamonkin PhD, Assistant Professor, Pathology & Immunology Center for Cell and Gene Therapy, Baylor College of Medicine
- Arthur Stril, VP Corporate Development, Cellectis